Literature DB >> 27592459

Procalcitonin levels predict to identify bacterial strains in blood cultures of septic patients.

Takao Arai1, Shoichi Ohta2, Junya Tsurukiri2, Kenichiro Kumasaka2, Katsuhiro Nagata2, Taihei Okita2, Taishi Oomura2, Akira Hoshiai2, Masaharu Koyama2, Tetsuo Yukioka2.   

Abstract

BACKGROUND: We examined whether the values obtained from principal component analysis (PCA) on laboratory tests can be used to predict bacterial infections and identify bacterial strains in blood culture (BC).
METHOD: This study is a single-center retrospective analysis of 315 patients suspected of having sepsis. We applied PCA on procalcitonin (PCT) and laboratory test biomarkers, namely, platelet (PLT), white blood cell, and C-reactive protein (CRP) as well as BC.
RESULTS: Principal component analysis showed that PCT, CRP, and PLT contributions to component 1 were associated with bacterial infection. The number of patients who had BC-negative results, gram-positive cocci (GPC), and gram-negative rods (GNRs) were 124, 28, and 19, respectively. The mean value of component 1 in GNR-positive patients was 1.58±1.41 and was significantly higher than that in GPC-positive patients (0.28±0.87; P<.0001). Furthermore, the mean values of component 1 in both GNR- and GPC-positive patients were significantly higher than that in BC-negative patients (-0.31±0.65; P<.0001 and P<.002, respectively). One certain range showing higher value more than 2.00 for component 1 and -1.00 for component 2 only included GNR-positive patients. There were no BC-positive patients who showed less than -1.00 for component 1.
CONCLUSION: The present results obtained by PCA on laboratory tests involving PCT, PLT, white blood cell, and CRP suggest the potential of PCA-obtained values to not only predict bloodstream infection but also identify bacterial strains. This provides some clinical significance in the management of sepsis in acute care.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27592459     DOI: 10.1016/j.ajem.2016.08.009

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.

Authors:  Xiaojiong Jia; Congya Li; Ju Cao; Xianan Wu; Liping Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-20       Impact factor: 3.267

2.  CRP/albumin ratio: A promising marker of gram-negative bacteremia in late-onset neonatal sepsis.

Authors:  Hatice Güneş; Sadık Yurttutan; Mustafa Çobanuşağı; Adem Doğaner
Journal:  Turk Arch Pediatr       Date:  2021-01-01

3.  Analgesic and Anti-Inflammatory Activities of Resveratrol through Classic Models in Mice and Rats.

Authors:  Guangxi Wang; Zhiqiang Hu; Xu Song; Qiankun Cui; Qiuting Fu; Renyong Jia; Yuanfeng Zou; Lixia Li; Zhongqiong Yin
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-13       Impact factor: 2.629

4.  Procalcitonin, C-Reactive Protein, Albumin, and Blood Cultures as Early Markers of Sepsis Diagnosis or Predictors of Outcome: A Prospective Analysis.

Authors:  Ana Cristina Schmidt de Oliveira-Netto; Luis G Morello; Libera M Dalla-Costa; Ricardo R Petterle; Rafael M Fontana; Danieli Conte; Luciane A Pereira; Sonia M Raboni
Journal:  Clin Pathol       Date:  2019-06-18

5.  Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.

Authors:  Mina Yang; Seung Jun Choi; Jaewoong Lee; Dong Gun Lee; Yoon-Joo Kim; Yeon-Joon Park; Eun-Jee Oh
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

6.  Best diagnostic accuracy of sepsis combining SIRS criteria or qSOFA score with Procalcitonin and Mid-Regional pro-Adrenomedullin outside ICU.

Authors:  Silvia Spoto; Edoardo Nobile; Emanuele Paolo Rafano Carnà; Marta Fogolari; Damiano Caputo; Lucia De Florio; Emanuele Valeriani; Domenico Benvenuto; Sebastiano Costantino; Massimo Ciccozzi; Silvia Angeletti
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.